These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 27599522

  • 21. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users.
    Frokjaer VG, Erritzoe D, Holst KK, Madsen KS, Fisher PM, Madsen J, Svarer C, Knudsen GM.
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1119-28. PubMed ID: 24524290
    [Abstract] [Full Text] [Related]

  • 22. Neuroimaging research in human MDMA users: a review.
    Cowan RL.
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [Abstract] [Full Text] [Related]

  • 23. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E.
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [Abstract] [Full Text] [Related]

  • 24. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.
    De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W.
    Int J Methods Psychiatr Res; 2005 Sep; 14(4):167-85. PubMed ID: 16395871
    [Abstract] [Full Text] [Related]

  • 25. Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users.
    Roberts CA, Jones A, Montgomery C.
    Neurosci Biobehav Rev; 2016 Apr; 63():158-67. PubMed ID: 26855234
    [Abstract] [Full Text] [Related]

  • 26. Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users.
    Roiser JP, Cook LJ, Cooper JD, Rubinsztein DC, Sahakian BJ.
    Am J Psychiatry; 2005 Mar; 162(3):609-12. PubMed ID: 15741482
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W.
    Lancet; 2001 Dec 01; 358(9296):1864-9. PubMed ID: 11741626
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J, Pubill D, Escubedo E.
    Brain Res; 2006 Sep 21; 1111(1):72-82. PubMed ID: 16889759
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC.
    Neurosci Biobehav Rev; 2013 Sep 21; 37(8):1466-84. PubMed ID: 23660456
    [Abstract] [Full Text] [Related]

  • 36. Human Ecstasy use is associated with increased cortical excitability: an fMRI study.
    Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL.
    Neuropsychopharmacology; 2011 May 21; 36(6):1127-41. PubMed ID: 21326196
    [Abstract] [Full Text] [Related]

  • 37. Human 5-HT transporter availability predicts amygdala reactivity in vivo.
    Rhodes RA, Murthy NV, Dresner MA, Selvaraj S, Stavrakakis N, Babar S, Cowen PJ, Grasby PM.
    J Neurosci; 2007 Aug 22; 27(34):9233-7. PubMed ID: 17715358
    [Abstract] [Full Text] [Related]

  • 38. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
    Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ.
    J Psychopharmacol; 2006 Mar 22; 20(2):164-75. PubMed ID: 16510475
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.